Skip to main content
Livermore
Livermore
ZHEN

Bender Robert & Associates

SEC CIK
0000894300
Latest filing
Jul 30, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Bender Robert & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
2,905
Value
$263.6K
% of portfolio
0.1%
Quarters held
21
Since Q1 2021
Holdings of ABT by Bender Robert & Associates, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,905$263.6K0.1%00.0%UnchangedHolders
Q1 20262,905$298.3K0.1%−200−6.4%ReducedHolders
Q4 20253,105$389.0K0.1%−960−23.6%ReducedHolders
Q3 20254,065$544.4K0.1%−50−1.2%ReducedHolders
Q2 20254,115$559.6K0.1%+30+0.7%AddedHolders
Q1 20254,085$541.9K0.1%−1,553−27.5%ReducedHolders
Q4 20245,638$637.7K0.2%−133−2.3%ReducedHolders
Q3 20245,771$658.0K0.1%+5,771NewHolders
Q2 20240$00.0%−6,817−100.0%Sold outHolders
Q1 20246,817$774.8K0.2%−317−4.4%ReducedHolders
Q4 20237,134$785.2K0.2%−182−2.5%ReducedHolders
Q3 20237,316$708.6K0.2%−825−10.1%ReducedHolders
Q2 20238,141$887.5K0.2%−580−6.7%ReducedHolders
Q1 20238,721$883.1K0.3%−5−0.1%ReducedHolders
Q4 20228,726$958.0K0.4%−260−2.9%ReducedHolders
Q3 20228,986$869.0K0.3%+280+3.2%AddedHolders
Q2 20228,706$946.0K0.4%−35−0.4%ReducedHolders
Q1 20228,741$1.03M0.3%−235−2.6%ReducedHolders
Q4 20218,976$1.06M0.3%00.0%UnchangedHolders
Q3 20218,976$1.06M0.3%−120−1.3%ReducedHolders
Q2 20219,096$1.05M0.3%+60+0.7%AddedHolders
Q1 20219,036$1.08M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.